Diagnostic methods for invasive fungal diseases in patients with hematologic malignancies
- PMID: 23216596
- PMCID: PMC3563387
- DOI: 10.1586/ehm.12.53
Diagnostic methods for invasive fungal diseases in patients with hematologic malignancies
Abstract
Invasive fungal disease is associated with increased morbidity and mortality in hematologic malignancy patients and hematopoietic stem cell transplant recipients. Timely recognition and treatment of invasive fungal diseases in these patients are essential and decrease mortality. However, conventional definitive diagnostic methods are difficult and time consuming. While conventional microbiological and histopathological methods are still needed for a definitive diagnosis of invasive fungal disease, new noninvasive diagnostic methods including serologic and molecular biomarkers are now available. These new diagnostic methods facilitate an early diagnosis of invasive fungal disease and allow for utilization of a pre-emptive treatment approach, which may ultimately lead to improved treatment outcomes and reduced toxicity.
Figures
Similar articles
-
Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia.PLoS One. 2015 Nov 10;10(11):e0140930. doi: 10.1371/journal.pone.0140930. eCollection 2015. PLoS One. 2015. PMID: 26554923 Free PMC article. Review.
-
Diagnostic strategies for invasive fungal infections in patients with hematologic malignancies and hematopoietic stem cell transplant recipients.J Natl Compr Canc Netw. 2013 Aug;11(8):941-9. doi: 10.6004/jnccn.2013.0115. J Natl Compr Canc Netw. 2013. PMID: 23946173
-
Evaluating the role of prophylaxis in the management of invasive fungal infections in patients with hematologic malignancy.Eur J Haematol. 2011 Oct;87(4):289-301. doi: 10.1111/j.1600-0609.2011.01682.x. Epub 2011 Aug 19. Eur J Haematol. 2011. PMID: 21752098 Review.
-
Considerations in the approach to invasive fungal infection in patients with haematological malignancies.Br J Haematol. 2008 Jan;140(2):133-52. doi: 10.1111/j.1365-2141.2007.06906.x. Br J Haematol. 2008. PMID: 18173752 Review.
-
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project.Haematologica. 2011 Sep;96(9):1366-70. doi: 10.3324/haematol.2011.042598. Epub 2011 May 12. Haematologica. 2011. PMID: 21565903 Free PMC article. Clinical Trial.
Cited by
-
Association of mannose-binding lectin levels and invasive fungal disease in hematologic malignancy patients receiving myelosuppressive chemotherapy or allogeneic hematopoietic stem cell transplantation.Bone Marrow Transplant. 2016 Sep;51(9):1228-32. doi: 10.1038/bmt.2016.92. Epub 2016 Apr 18. Bone Marrow Transplant. 2016. PMID: 27088382
-
Invasive Fungal Infections in Children with Acute Leukemia: Epidemiology, Risk Factors, and Outcome.Microorganisms. 2024 Jan 11;12(1):145. doi: 10.3390/microorganisms12010145. Microorganisms. 2024. PMID: 38257971 Free PMC article.
-
A case of Magnusiomyces capitatus isolated during monitoring in an antimicrobial diagnostic stewardship context.IDCases. 2024 Apr 15;36:e01959. doi: 10.1016/j.idcr.2024.e01959. eCollection 2024. IDCases. 2024. PMID: 38681078 Free PMC article.
-
Evaluation of Commercially Available Real-Time Polymerase Chain Reaction Assays for the Diagnosis of Invasive Aspergillosis in Patients with Haematological Malignancies.Mycopathologia. 2020 Apr;185(2):269-277. doi: 10.1007/s11046-020-00424-1. Epub 2020 Jan 16. Mycopathologia. 2020. PMID: 31950340
-
Production of the Invasive Aspergillosis Biomarker Bis(methylthio)gliotoxin Within the Genus Aspergillus: In Vitro and in Vivo Metabolite Quantification and Genomic Analysis.Front Microbiol. 2018 Jun 12;9:1246. doi: 10.3389/fmicb.2018.01246. eCollection 2018. Front Microbiol. 2018. PMID: 29946309 Free PMC article.
References
-
- Pfaller MA, Pappas PG, Wingard JR. Invasive fungal pathogens: current epidemiological trends. Clin. Infect. Dis. 2006;43(1):S3–S14.
-
- Pagano L, Caira M, Candoni A, et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica. 2006;91(8):1068–1075. - PubMed
-
- Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 2002;34(7):909–917. - PubMed
-
- Pagano L, Caira M, Nosari A, et al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study–Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin. Infect. Dis. 2007;45(9):1161–1170. - PubMed
-
- Lass-Flörl C. The changing face of epidemiology of invasive fungal disease in Europe. Mycoses. 2009;52(3):197–205. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical